FBIO Fortress Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FBIO

Price (delayed)

$1.75

Market cap

$33.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.47

Enterprise value

$35.89M

Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in ...

Highlights
Fortress Biotech's EPS has increased by 47% YoY and by 32% QoQ
FBIO's net income is up by 30% YoY and by 23% QoQ
The company's equity fell by 46% YoY but it rose by 35% QoQ
FBIO's quick ratio is up by 36% QoQ but it is down by 29% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fortressbiotech.com
Peers: VCYT ADXS DVAX ALKS

Key stats

What are the main financial stats of FBIO
Market
Shares outstanding
19.23M
Market cap
$33.66M
Enterprise value
$35.89M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
0.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.42
Earnings
Revenue
$84.51M
EBIT
-$44.8M
EBITDA
-$36.73M
Free cash flow
-$122.29M
Per share
EPS
-$8.47
Free cash flow per share
-$15.08
Book value per share
$2.52
Revenue per share
$10.42
TBVPS
$18.15
Balance sheet
Total assets
$167.53M
Total liabilities
$165.94M
Debt
$85.59M
Equity
$22.54M
Working capital
$32.11M
Liquidity
Debt to equity
3.8
Current ratio
1.38
Quick ratio
1.16
Net debt/EBITDA
-0.06
Margins
EBITDA margin
-43.5%
Gross margin
68.5%
Net margin
-71.7%
Operating margin
-168.4%
Efficiency
Return on assets
-36%
Return on equity
-287.5%
Return on invested capital
-94.7%
Return on capital employed
-54.2%
Return on sales
-53%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
-2.78%
1 week
1.74%
1 month
-8.85%
1 year
-84.2%
YTD
-41.86%
QTD
-12.5%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$84.51M
Gross profit
$57.85M
Operating income
-$142.34M
Net income
-$60.64M
Gross margin
68.5%
Net margin
-71.7%
The net margin has increased by 37% YoY and by 26% QoQ
FBIO's operating margin is up by 37% year-on-year and by 23% since the previous quarter
FBIO's operating income is up by 30% YoY and by 20% from the previous quarter
FBIO's net income is up by 30% YoY and by 23% QoQ

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
N/A
P/B
0.69
P/S
0.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.42
Fortress Biotech's EPS has increased by 47% YoY and by 32% QoQ
The P/B is 77% less than the 5-year quarterly average of 3.0 and 73% less than the last 4 quarters average of 2.6
The company's equity fell by 46% YoY but it rose by 35% QoQ
The P/S is 94% below the 5-year quarterly average of 2.8 and 76% below the last 4 quarters average of 0.7
FBIO's revenue is up by 12% year-on-year and by 4.4% since the previous quarter

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity has shrunk by 112% YoY but it rose by 2.2% QoQ
Fortress Biotech's return on sales has increased by 45% YoY and by 28% QoQ
The ROA has declined by 32% year-on-year but it has grown by 5% since the previous quarter
FBIO's return on invested capital is up by 19% since the previous quarter but it is down by 15% year-on-year

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets has contracted by 43% YoY but it has grown by 11% from the previous quarter
Fortress Biotech's current ratio has increased by 38% from the previous quarter but it has decreased by 23% YoY
The company's equity fell by 46% YoY but it rose by 35% QoQ
The debt to equity is up by 31% year-on-year but it has declined by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.